Massachusetts Financial Services
GSK icon

Massachusetts Financial Services’s GSK GSK Stock Holding History

Massachusetts Financial Services’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8M Buy
319,805
+107,439
+51% +$5.68M 0.01% 700
2026
Q1 		$11.7M Buy
+212,366
New +$11.5M ﹤0.01% 716
2014
Q4 		– Sell
-74,024
Closed -$4.25M – 893
2014
Q3 		$4.25M Sell
74,024
-574
-0.8% -$35.2K ﹤0.01% 690
2014
Q2 		$4.99M Sell
74,598
-14,440
-16% -$977K ﹤0.01% 666
2014
Q1 		$5.95M Sell
89,038
-3,720
-4% -$251K ﹤0.01% 612
2013
Q4 		$6.19M Buy
92,758
+1,803
+2% +$117K ﹤0.01% 592
2013
Q3 		$5.7M Sell
90,955
-726
-0.8% -$46.7K ﹤0.01% 597
2013
Q2 		$5.73M Buy
+91,681
New +$5.82M ﹤0.01% 574

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Massachusetts Financial Services's GSK Position: Q2 2026 in Review

Massachusetts Financial Services increased its GSK (GSK) stake by 51% in Q2 2026, buying an estimated $5.68M and bringing the position to 319,805 shares worth $16.8M. The position accounts for 0.01% of the portfolio, ranked #700.

Massachusetts Financial Services first reported a position in GSK in Q2 2013 and has held it in 8 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Massachusetts Financial Services held 319,805 shares of GSK worth $16.8M as of Q2 2026.
  • Massachusetts Financial Services bought 107,439 GSK shares in Q2 2026, an estimated $5.68M.
  • GSK made up 0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #700 holding.
  • Massachusetts Financial Services first reported a position in GSK in Q2 2013 and has held it in 8 quarters since.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.